First FDA-Cleared Respirators For General Public Use In Public Health Medical Emergencies Now Available From 3M

Main Category: Respiratory / Asthma
Also Included In: Medical Devices / Diagnostics;  Regulatory Affairs / Drug Approvals
Article Date: 20 May 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Healthcare Prof:5 stars

5 (3 votes)


Consumers concerned about an influenza outbreak can breathe a little easier: 3M has just released two new NIOSH N95 respirators for use by the general public in public health medical emergencies.

These two respirators - 3M™ Particulate Respirator 8612F and 3M™ Particulate Respirator 8670F - are unique because they are the first to receive clearance by the U.S. Food & Drug Administration (FDA) to reduce exposure to airborne germs during a public health medical emergency such as an influenza pandemic. The FDA outlined a special clearance process for N95 respirators used by the general public in public health medical emergencies in order to provide reasonable assurance of their safety and effectiveness.

Although use of respirators is only one of several precautions that can be taken in response to a public health medical emergency, "The release of these FDA-N95 respirators is a significant step in providing the public with guidance and products needed to help reduce exposure to airborne germs," said Julie Bushman, division vice-president, 3M Occupational Health and Environmental Safety Division.

According to Bushman, 3M is taking steps to ensure the respirators are readily available to the public. "The need has grown as more people realize the importance of planning ahead for a public health medical emergency," Bushman said.

3M™ Particulate Respirator 8612F and 3M™ Particulate Respirator 8670F can be purchased from one of the many medical, safety and industrial distributors that carry 3M products. Additionally, these new products will be available under the Nexcare™ brand in select retail pharmacies. Both products can also be purchased from the company's online store, http://www.3MeStore.com, or by calling 1-800-234-8068.

For technical information about proper use of these 3M respirators, visit http://www.my3MN95.com.

About 3M

A recognized leader in research and development, 3M produces thousands of innovative products for dozens of diverse markets. 3M's core strength is applying its more than 40 distinct technology platforms - often in combination - to a wide array of customer needs. With $25 billion in sales, 3M employs 75,000 people worldwide and has operations in more than 60 countries.

http://www.mmm.com

Article adapted by Medical News Today from original press release.
Visit our respiratory / asthma section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
3M. "First FDA-Cleared Respirators For General Public Use In Public Health Medical Emergencies Now Available From 3M." Medical News Today. MediLexicon, Intl., 20 May. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/107952.php>

APA
3M. (2008, May 20). "First FDA-Cleared Respirators For General Public Use In Public Health Medical Emergencies Now Available From 3M." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/107952.php.

Please note: If no author information is provided, the source is cited instead.


Respiratory / Asthma

What is Asthma?

Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition (long-lasting or recurrent) are said to be asthmatic. Read more...

Most Popular Articles



Follow Our Respiratory News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Respiratory / Asthma Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »